Peripheral Blood Stem Cell TransplantationGranulocyte Colony-Stimulating FactorHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation, AutologousBone MarrowBone Marrow CellsGranulocytesHematopoietic Stem CellsBone Marrow TransplantationLeukapheresisStem CellsTransplantation, HomologousBlood Component RemovalAntigens, CD34Transplantation ConditioningHematologic NeoplasmsGraft vs Host DiseaseHematopoiesisMelphalanCyclophosphamideCombined Modality TherapyReceptors, Granulocyte Colony-Stimulating FactorBone and BonesGraft SurvivalNeutropeniaLeukocyte CountMultiple MyelomaBlood CellsStem Cell TransplantationBusulfanRecombinant ProteinsColony-Forming Units AssayAntineoplastic Combined Chemotherapy ProtocolsBone Marrow DiseasesBlood Cell CountCord Blood Stem Cell TransplantationTreatment OutcomeLymphoma, Non-HodgkinBone Marrow PurgingCell DifferentiationTissue DonorsGranulocyte-Macrophage Colony-Stimulating FactorEtoposideCells, CulturedAntineoplastic Agents, AlkylatingMyeloablative AgonistsWhole-Body IrradiationTransplantation ChimeraThiotepaRecurrenceVision, EntopticColony-Stimulating FactorsRemission InductionHistocompatibilityLeukemiaCell SeparationPlatelet CountFlow CytometryTime FactorsNeutrophilsAnemia, AplasticBlood DonorsHistocompatibility TestingIfosfamideImmunophenotypingCytarabineEmbryonic Stem CellsLeukocytes, MononuclearLeukemia, Myeloid, AcuteDisease-Free SurvivalInfectionAdult Stem CellsStem Cell FactorTransplantation, IsogeneicAntigens, CDInterleukin-3VincristineVidarabineBone RemodelingPOEMS SyndromeInjections, SubcutaneousRetrospective StudiesImmunosuppressive AgentsImmunomagnetic SeparationSalvage TherapySurvival RateBone Marrow ExaminationHodgkin DiseaseT-LymphocytesLymphomaLeukocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival AnalysisNeoplasmsMyelodysplastic SyndromesCarmustineBone Marrow NeoplasmsLeukocyte TransfusionCell Division